[Treatment of the Ehlers-Danlos syndrome with zinc (author's transl)].
Oral administration of zinc sulfate did not improve the clinical conditions in two patients with Ehlers-Danlos-Syndrome type I. Zinc levels in serum and hair were normal before and during treatment.
D000293:Adolescent; D002675:Child, Preschool; D004535:Ehlers-Danlos Syndrome / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006197:Hair / Q000032:analysis; D006801:Humans; D008297:Male; D015032:Zinc / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*
D015032:Zinc
Die Behandlung des Ehlers-Danlos-Syndroms mit Zink.